Ascendis Pharma A/S vs Alkermes plc: Annual Revenue Growth Compared

Biotech Giants: Revenue Growth Showdown

__timestampAlkermes plcAscendis Pharma A/S
Wednesday, January 1, 201461878900013983000
Thursday, January 1, 20156283350008118000
Friday, January 1, 20167456940004606000
Sunday, January 1, 20179033740001530000
Monday, January 1, 2018109427400010581000
Tuesday, January 1, 2019117094700013375000
Wednesday, January 1, 202010387560006953000
Friday, January 1, 202111737510007778000
Saturday, January 1, 2022111179500051174000
Sunday, January 1, 20231663405000266718000
Monday, January 1, 20241557632000363641000
Loading chart...

Cracking the code

A Tale of Two Biotechs: Revenue Growth of Ascendis Pharma A/S and Alkermes plc

In the dynamic world of biotechnology, revenue growth is a key indicator of a company's success and market position. This chart compares the annual revenue growth of Ascendis Pharma A/S and Alkermes plc from 2014 to 2023. Over this period, Alkermes plc has shown a steady increase in revenue, peaking in 2023 with a 169% growth from its 2014 figures. In contrast, Ascendis Pharma A/S, while starting with a modest revenue, experienced a remarkable surge in 2023, achieving a growth rate of over 1800% compared to its 2014 revenue. This dramatic increase highlights Ascendis Pharma's potential and strategic advancements in the biotech sector. The data underscores the importance of innovation and strategic planning in driving revenue growth in the competitive pharmaceutical industry.

Published by
U.S. Securities and Exchange Commission

Source link
sec.gov

Date published
17 Jan 2025